PALISADE BIO, INC. (PALI) Form 10-Q Quarterly Reports
PALISADE BIO, INC. (PALI) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PALI
CIK: 1357459
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Baker Tilly US, LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerBrian Francese
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-07 | 2026-10-06 | 4 | 0001493152-26-046202 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-06 | 4 | 0001493152-26-046201 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | 4 | 0001493152-26-045772 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 | 0001493152-26-039746 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001831942-26-000040 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-088750 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001357459-26-000017 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001357459-26-000016 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-29 | — | SCHEDULE 13G Filing | 0002012383-26-002923 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | 4 | 0001493152-26-032884 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | 4 | 0001493152-26-032563 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | 4 | 0001493152-26-032561 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | 4 | 0001493152-26-032559 | View SEC Doc Filr Page |
| 144 | 2026-07-07 | — | 144 Filing | 0001974078-26-000267 | View SEC Doc Filr Page |
| 144 | 2026-07-07 | — | 144 Filing | 0001974078-26-000266 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001493152-26-032229 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-10 | 4 | 0001493152-26-029329 | View SEC Doc Filr Page |
| 3 | 2026-06-18 | 2026-06-10 | 3 | 0001493152-26-029315 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 | 0001493152-26-028574 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 | 0001493152-26-028572 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 | 0001493152-26-028570 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 | 0001493152-26-028568 | View SEC Doc Filr Page |
| 3 | 2026-06-12 | 2026-06-10 | 3 | 0001493152-26-028566 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-10 | 8-K | 0001493152-26-028322 | View SEC Doc Filr Page |
| S-8 | 2026-06-10 | — | S-8 | 0001493152-26-028123 | View SEC Doc Filr Page |